- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02763683
Investigations of Dementia in Parkinson Disease (PIB)
Study Overview
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Kaleigh Oberndorfer, RN, BSN
- Phone Number: 314 3620420
- Email: kaleigh@wustl.edu
Study Contact Backup
- Name: Susan Donovan
- Phone Number: 314 362 6026
- Email: donovan@wustl.edu
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Recruiting
- Washington University in St. Louis
-
Contact:
- Susan Donovan, BSN
- Phone Number: 314-362-6026
- Email: donovan@wustl.edu
-
Contact:
- Kaleigh Oberndorfer
- Phone Number: 314 362 0420
- Email: kaleigh@wustl.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- PD patients must exhibit three of the following cardinal signs: rest tremor, rigidity, bradykinesia, or postural instability; or two of these features with one of the first three displaying asymmetry.
Exclusion Criteria:
- history of head trauma, major neurological or psychiatric diseases other than Parkinson disease and dementia, e.g. stroke, multiple sclerosis, depression or schizophrenia.
- severe systemic diseases.
- inability to lie still for 90 minutes.
- metallic implants, pacemakers, or any other contraindication to MRI.
- refusal to consent to brain donation.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Parkinsons Disease
Individuals with Parkinsons Disease
|
There is no intervention for this study.
The PiB and VAT are used during the PET procedures to help to identify any excessive abnormal proteins in the brain.
|
Healthy Controls
Individuals without Parkinsons Disease
|
There is no intervention for this study.
The PiB and VAT are used during the PET procedures to help to identify any excessive abnormal proteins in the brain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Investigations of Dementia in Parkinsons Disease
Time Frame: 2030
|
The investigators will perform memory/thinking testing, Lumbar puncture (LP), Magnetic Resonance Imaging (MRI) and (PET) scans to help to determine the cause(s) of memory and thinking in Parkinson Disease. The memory and thinking testing by phone on average at 1.5 years through study completion and then in person on average at 3 years through study completion, this will help monitor if there is any decline in memory and thinking. The Lumbar Puncture is done on willing participants on average at 3 years through study completion to assess for any abnormal proteins and correlate these with any changes in memory and thinking. The MRI is done on average at 3 years through study completion for any abnormal signs or changes in regards to dementia at 3 years. The (PiB) & (VAT) PET scans will be performed on average at 3 years through study completion, which will be analyzed to assess for changes in regards to abnormal proteins and signs of dementia. |
2030
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Joel S Perlmutter, MD, Washington University School of Medicine
Study record dates
Study Major Dates
Study Start
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201512032
- R01NS075321 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- ICF
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinsons
-
University of California, San FranciscoNovartisCompletedParkinsons Disease With Dementia | Parkinsons Disease With Mild to Moderate Memory and/or Thinking ProblemsUnited States
-
Diskapi Teaching and Research HospitalCompleted
-
Hoffmann-La RocheProthena Biosciences LimitedActive, not recruitingParkinsons DiseaseUnited States, United Kingdom, Canada, France, Luxembourg, Poland, Spain, Italy, Austria
-
NYU Langone HealthTerminatedParkinsons DiseaseUnited States
-
Beth Israel Deaconess Medical CenterCompletedParkinsons DiseaseUnited States
-
University of VirginiaCompletedParkinsons DiseaseUnited States
-
University of FloridaMedtronic; Michael J. Fox Foundation for Parkinson's ResearchCompletedParkinsons DiseaseUnited States
-
Institut National de la Santé Et de la Recherche...Unknown
Clinical Trials on PiB and VAT
-
José A. LuchsingerNational Institute on Aging (NIA); Wake Forest UniversityEnrolling by invitationVascular Diseases | Atherosclerosis | Cognitive Impairment | Alzheimer DiseaseUnited States
-
Boehringer IngelheimCompleted
-
University of Southern CaliforniaNational Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Alzheimer's Clinical Trials ConsortiumRecruitingDementia | Alzheimer Disease | Down SyndromeUnited States, Spain, United Kingdom
-
Vedea Healthware BVElisabeth-TweeSteden Ziekenhuis; Jeroen Bosch Ziekenhuis; Health Holland; Oogziekenhuis... and other collaboratorsRecruitingAmblyopia | Amblyopia, Anisometropic | Amblyopia StrabismicNetherlands
-
Oriental Neurosurgery Evidence-Based-Study TeamUnknownParkinson DiseaseChina
-
Johns Hopkins UniversityNational Institute on Aging (NIA)CompletedAlzheimer's DiseaseUnited States
-
Avid RadiopharmaceuticalsGeneral Electric; American College of Radiology Imaging NetworkCompletedAlzheimer's DiseaseUnited States
-
Hospital Sirio-LibanesHospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital do Coracao and other collaboratorsRecruitingTracheobronchitis | Ventilator Associated TracheobronchitisBrazil
-
JhpiegoBotswana Ministry of HealthCompletedCervical Cancer | Human Papillomavirus InfectionBotswana
-
University of North Carolina, Chapel HillBoston Children's Hospital; Medical College of Wisconsin; National Football LeagueEnrolling by invitation